Dr Jitendra Singh Proposes India-Delaware Biomanufacturing Working Group
Dr Jitendra Singh proposed an India-Delaware Biomanufacturing Working Group to boost biotech collaboration, highlighting startup and R&D linkages. He also stressed supply chain resilience and regulatory cooperation during India-US talks to strengthen innovation, manufacturing and strategic life sciences ties.
Supply Chain Resilience | 03/03/2026 | By News Bureau
Where Will Pharma Investments Head Next?
As India’s pharma sector shifts from a volume-driven generics model to an innovation-led ecosystem, its investment landscape is rapidly transforming. Ambitions to become a global innovation hub are pushing companies to rethink capital allocation, with R&D, manufacturing diversification, and digital transformation emerging as priorities.
Supply Chain Resilience | 03/12/2025 | By Akanki | 397
Eli Lilly has voiced opposition to proposed tariffs on pharmaceutical products, cautioning that such measures could increase costs, limit patient access, and weaken US leadership in biopharmaceutical innovation.
Supply Chain Resilience | 16/08/2025 | By Dineshwori | 210
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy